Search
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 421 - 435 of 534 items.
PrBENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury
AlertHealth professional risk communication | 2019-04-04
Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure
AlertInformation update | 2019-04-04
DARZALEX (daratumumab) and Hepatitis B Virus Reactivation
AlertHealth professional risk communication | 2019-03-25
Pro Doc Limitée voluntarily recalls two lots of irbesartan drugs because of nitrosamine impurity
AlertInformation update | 2019-03-14
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Myositis
AlertHealth professional risk communication | 2019-03-13
Multiple Losartan-containing drugs voluntarily recalled because of potential for nitrosamine impurity
AlertInformation update | 2019-03-09
Homeopathic remedies are not a substitute for vaccines
AlertInformation update | 2019-03-06
Bedbugs: Don't bring them back from your vacation
AlertInformation update | 2019-03-05
Health Canada recommends that children and youth not use cough and cold products that contain opioids
AlertInformation update | 2019-02-18
Health Canada will be updating its safety review of breast implants
AlertInformation update | 2019-02-12
Important new safety information regarding the use of hydrochlorothiazide and the risk of non-melanoma skin cancer
AlertInformation update | 2019-01-31
LARTRUVO (olaratumab) - New clinical trial information important to prescribing decisions
AlertHealth professional risk communication | 2019-01-30